Copyright
©2012 Baishideng Publishing Group Co.
World J Gastroenterol. Sep 21, 2012; 18(35): 4866-4874
Published online Sep 21, 2012. doi: 10.3748/wjg.v18.i35.4866
Published online Sep 21, 2012. doi: 10.3748/wjg.v18.i35.4866
Table 1 Macroscopic results
| Group | I (n = 14) | II (n = 15) | III (n = 11) | IV (n = 6) | V (n = 5) | VI (n = 6) |
| Inflammation | 14 | 15 | 11 | 6 | 5 | 6 |
| Ulcerated mucosa,% | 35.7 | 37.3 | 33.18 | 39.58 | 16 | 14.17 |
| Squamous hyperplasia,% | 10 | 14 | 2 | 5 | 2 | 2 |
| Intestinal metaplasia in continuity with anastomosis, mm | 2.29 | 3.5 | 2.32 | 2.83 | 2 | 1.25 |
| Intestinal metaplasia beyond anastomosis,% | 10 | 9 | 5 | 4 | 1 | 0 |
| Dysplasia | 14 | 14 | 10 | 6 | 5 | 5 |
| High-grade dysplasia/low-to-medium grade dysplasia | 10/4 | 12/2 | 4/6 | 4/2 | 0/5 | 1/4 |
| Neoplasia | 8 | 9 | 4 | 3 | - | - |
| Mucinous adenocarcinoma | 7 | 9 | 3 | 2 | - | - |
| Squamous adenocarcinoma | 1 | - | 1 | 1 | - | - |
- Citation: Esquivias P, Morandeira A, Escartín A, Cebrián C, Santander S, Esteva F, García-González MA, Ortego J, Lanas A, Piazuelo E. Indomethacin but not a selective cyclooxygenase-2 inhibitor inhibits esophageal adenocarcinogenesis in rats. World J Gastroenterol 2012; 18(35): 4866-4874
- URL: https://www.wjgnet.com/1007-9327/full/v18/i35/4866.htm
- DOI: https://dx.doi.org/10.3748/wjg.v18.i35.4866